Jessica Hankins PhD Bristol Myers Squibb

Jessica Hankins holds a PhD with distinction from Georgia Health Sciences University where she studied endotoxin biosynthesis of various Gram-negative organisms in the laboratory of M. Stephen Trent. Following a post-doctoral fellowship at The University of Texas at Austin and a position in Genentech's Early Research and Development Infectious Diseases department, Jessica joined the Food and Drug Administration as a microbiology reviewer and Quality Assessment Lead in the Center for Drug Evaluation and Research. Currently, Jessica is a Director at Bristol Myers Squibb, where her team oversees container closure integrity test method development and validation, as well as endotoxin method development and verification. She is a member of the U.S. Pharmacopeia Microbiology Expert Committee.